Effects of Long-Term Treatment with Antidepressant Drugs on Proopiomelanocortin and Neuropeptide Y mRNA Expression in the Hypothalamic Arcuate Nucleus of Rats

1996 ◽  
Vol 8 (5) ◽  
pp. 337-343 ◽  
Author(s):  
Ross A. Baker ◽  
Miles Herkenham ◽  
Linda S. Brady
Keyword(s):  
Neuropeptide Y ◽  
Mrna Expression ◽  
Arcuate Nucleus ◽  
Antidepressant Drugs ◽  
Term Treatment ◽  
Long Term Treatment ◽  
Hypothalamic Arcuate Nucleus

Long-term treatment with angiotensin II type 1 receptor antagonist, CV-11974, restores β-catenin mRNA expression in volume-overloaded rabbit hearts

2002 ◽  
Vol 17 (1) ◽  
pp. 36-41 ◽  
Author(s):  
Makoto Itoh ◽  
Y. Takeishi ◽  
Shigekazu Nakada ◽  
Takuya Miyamoto ◽  
Yuichi Tsunoda ◽  
...  
Keyword(s):  
Angiotensin Ii ◽  
Receptor Antagonist ◽  
Mrna Expression ◽  
Term Treatment ◽  
Long Term Treatment

Prevention of the stress-induced increase in frontal cortical dopamine efflux of freely moving rats by long-term treatment with antidepressant drugs

2001 ◽  
Vol 11 (5) ◽  
pp. 343-349 ◽  
Author(s):  
Laura Dazzi ◽  
Mariangela Serra ◽  
Francesca Spiga ◽  
M.Giuseppina Pisu ◽  
J.David Jentsch ◽  
...  
Keyword(s):  
Antidepressant Drugs ◽  
Term Treatment ◽  
Freely Moving Rats ◽  
Long Term Treatment ◽  
Freely Moving ◽  
Dopamine Efflux

Pharmacotherapy of Bipolar Disorder

2016 ◽  
pp. 384-397
Author(s):  
Jay D. Amsterdam ◽  
Janusz K. Rybakowski
Keyword(s):  
Bipolar Disorder ◽  
First Generation ◽  
Psychiatric Comorbidity ◽  
Antidepressant Drugs ◽  
Term Treatment ◽  
Affective States ◽  
Pharmacological Interventions ◽  
Long Term Treatment ◽  
Depressive Episodes

Bipolar disorder (BD) is a recurrent and often chronic condition that is characterized by episodes of mania, hypomania, depression, and mixed affective states. BD affects up to 5% of the population, ranks sixth as a cause of worldwide disability among persons 15 to 44 years old, and has an estimated lifetime suicide rate of 10–20%. Pharmacotherapy remains one of the most important interventions for initial and long-term treatment of BD. In this chapter, pharmacological interventions for acute manic episodes, for acute depressive episodes, and for the prevention of recurrent affective episodes of either type are systematically presented, with special emphasis on the use of first-generation and second-generation mood-stabilizing drugs and antidepressant drugs. Special issues related to pharmacotherapy of BD are also discussed such as rapid cycling BD, mixed affective states, psychiatric comorbidity, and pregnancy and the postpartum period.

Sign in / Sign up

Export Citation Format

Share Document